protoporphyrin ix has been researched along with camptothecin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, I; Hefti, M; Luginbuehl, V | 1 |
| Chung, LY; Imae, T; Kiew, LV; Kiew, SF; Lee, HB; Looi, CY; Siriviriyanun, A; Tsai, YJ; Voon, SH; Wong, WF | 1 |
2 other study(ies) available for protoporphyrin ix and camptothecin
| Article | Year |
|---|---|
Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.
Topics: Aged; Aminolevulinic Acid; Antineoplastic Agents, Phytogenic; Camptothecin; Caspase 3; Cell Culture Techniques; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Survival; Extracellular Matrix Proteins; Female; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Oxygen; Photochemotherapy; Protoporphyrins | 2014 |
Cyclodextrin- and dendrimer-conjugated graphene oxide as a nanocarrier for the delivery of selected chemotherapeutic and photosensitizing agents.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Cell Survival; Cyclodextrins; Dendrimers; Doxorubicin; Drug Carriers; Drug Liberation; Graphite; Humans; Light; Microscopy, Atomic Force; Oxides; Photosensitizing Agents; Protoporphyrins | 2018 |